Sho Sasaki

Sho Sasaki

Auto-generated profile, based on publicly available information

Sho Sasaki

Clinical research support office, Iizuka Hospital, Iizuka City, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2001 in Nature
Verified
Journal Article
Closed access
PDF file
SSSho Sasaki
Sho Sasaki
KNKeiko Nakamura
Keiko Nakamura
YHYoshimi Hamabe
Yoshimi Hamabe
EKErika Kurahashi
Erika Kurahashi
THTakahiro Hiroi
Takahiro Hiroi

1 February 1997 in Geophysical Research Letters
Verified
Journal Article
Closed access
PDF file
GHGeorge L. Hashimoto
George L. Hashimoto
YAYutaka Abe
Yutaka Abe
SSSho Sasaki
Sho Sasaki

12 May 2017 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
PDF file
TITakahiro Imaizumi
Takahiro Imaizumi
THTakeshi Hasegawa
Takeshi Hasegawa
ANAtsushi Nomura
Atsushi Nomura
SSSho Sasaki
Sho Sasaki
HNHiroki Nishiwaki
Hiroki Nishiwaki
YFYoshiro Fujita
Yoshiro Fujita

27 June 2013 in Transplantation
Verified
Journal Article
Closed access
NINaohiko Imai
Naohiko Imai
DUDaisuke Uchida
Daisuke Uchida
MHMasaya Hanada
Masaya Hanada
SSSho Sasaki
Sho Sasaki
YSYugo Shibagaki
Yugo Shibagaki
KKKenjiro Kimura
Kenjiro Kimura

1 February 2014
Verified
Journal Article
Closed access
SSSho Sasaki
Sho Sasaki
NSNobuyuki Sueyoshi
Nobuyuki Sueyoshi
YYYuko Yamaoka
Yuko Yamaoka
YYYuhi Yano
Yuhi Yano
YHYasuhide Hiroyoshi
Yasuhide Hiroyoshi
KTKazuhiro Teramura
Kazuhiro Teramura

1 July 2017 in ASAIO Journal
Verified
Journal Article
Closed access
DUDaisuke Uchida
Daisuke Uchida
SSSho Sasaki
Sho Sasaki
HKHiroo Kawarazaki
Hiroo Kawarazaki
MMMasahito Miyamoto
Masahito Miyamoto
ANAtsushi Nomura
Atsushi Nomura
YSYugo Shibagaki
Yugo Shibagaki
Bloodstream infection (BSI) in hemodialysis (HD) patients is often difficult to diagnose. Systemic inflammatory response syndrome (SIRS) is a sensitive predictor of BSI in the general population. We aimed to assess the usefulness of SIRS in predicting BSI in HD patients. We designed a multicenter retrospective observational study of adult (age > 18 years) HD patients who underwent two sets of blood cultures for suspected BSI at first hospital visit from August 2011 to July 2012. Clinical, biological, and microbial data were evaluated to evaluate SIRS as a predictor of BSI upon initial presentation to the hospital. Data were obtained from 279 HD patients. Vascular access other than arteriovenous fistula and subcutaneously fixed superficial artery, and those administered antimicrobial drugs before visit were excluded; thus, a total of 202 patients were finally enrolled. Mean patient age was 71 years, 67.3% were male, 49.3% had diabetes, 28.2% had indwelling hardware, and 18.3% patients had BSI. Endocarditis and vertebral osteomyelitis were common infection sites, and Staphylococcus aureus was the most common pathogen. Of those with SIRS, 25.3% had BSI and 74.7% did not (odds ratio for SIRS, 2.10; 95% confidence interval, 0.90-4.91; p = 0.11). Thus, SIRS had a low sensitivity for predicting BSI in HD patients (sensitivity, 71.9%; specificity, 45.2%; positive likelihood ratio, 1.31; negative likelihood ratio, 0.62). Systemic inflammatory response syndrome has low sensitivity in identifying BSI in HD patients. A low threshold for drawing blood cultures and initiating antibiotic treatment should be considered for HD patients.